BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6184513)

  • 21. Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.
    Chu TM; Wang MC; Scott WW; Gibbons RP; Johnson DE; Schmidt JD; Loening SA; Prout GR; Murphy GP
    Invest Urol; 1978 Jan; 15(4):319-23. PubMed ID: 75196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with prostate-specific antigen in patients with prostatic cancer].
    Romics I; Bach D
    Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate].
    Perrin P; Clairet F; Fleury-Goyon MC; Durand L
    J Urol (Paris); 1984; 90(1):19-22. PubMed ID: 6202800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid phosphatase isozymes in cancer of the prostate.
    Reif AE; Schlesinger RM; Fish CA; Robinson CM
    Cancer; 1973 Mar; 31(3):689-99. PubMed ID: 4120927
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 26. Arginase in human urogenital tumors.
    Yamanaka H; Mayuzumi T; Matsuoka M; Shimazaki J; Shida K
    Gan; 1972 Dec; 63(6):693-700. PubMed ID: 4119243
    [No Abstract]   [Full Text] [Related]  

  • 27. [Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1484-8. PubMed ID: 6164809
    [No Abstract]   [Full Text] [Related]  

  • 28. [Urogenital cancer and aldolase].
    Kurokawa K; Terao H; Fujimura N
    Nihon Ishikai Zasshi; 1968 Sep; 60(5):416-20. PubMed ID: 5751446
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
    Rassweiler J; Lutz K; Müller HA; Eisenberger F
    Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical identification of prostatic epithelial cells in culture.
    Pontes JE; Choe B; Rose N; Pierce JM
    Invest Urol; 1979 May; 16(6):483-5. PubMed ID: 87387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum gamma-seminoprotein determination in prostatic cancer.
    Shimazaki J; Akimoto S; Akakura K; Yoshiki T; Yoshida O; Okada K; Matsuoka K; Noda S; Eto K
    Hinyokika Kiyo; 1991 Apr; 37(4):341-7. PubMed ID: 1716404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunochemical analysis of prostatic acid phosphatase. 1. Experimental study for the establishment of the immunochemical method].
    Sakai S; Kato N; Kawada Y; Nishiura T; Sawada H
    Nihon Hinyokika Gakkai Zasshi; 1982 May; 73(5):590-8. PubMed ID: 6757508
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase].
    Bauer HW; Schüller J; Schmiedt E; Dati F
    Helv Chir Acta; 1981 Aug; 48(3-4):459-63. PubMed ID: 7026510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of determining prostatic acid phosphatases by a radioimmunological method in cases of bony metastases].
    Mattei JP; Imbert I; Laugier-Catenacci E; Roux H
    Rev Rhum Mal Osteoartic; 1989 Feb; 56(2):147-9. PubMed ID: 2471253
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of various manipulations on serum phosphatase levels in benign disease.
    Greene FT; Thompson IM
    J Urol; 1974 Aug; 112(2):232-6. PubMed ID: 4135604
    [No Abstract]   [Full Text] [Related]  

  • 39. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology.
    Panteghini M; Pagani F; Bonora R
    Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):135-9. PubMed ID: 1376155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma].
    Korth K; Wetterauer W; Wetterauer U; Heite HJ
    Hautarzt; 1978 Sep; 29(9):487-9. PubMed ID: 81063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.